News People with PMOS should have yearly checks: NICE Polyendocrine metabolic ovarian syndrome is often under-diagnosed and inconsistently managed Sreedevi N R Jul 01, 2026
News We risk sleepwalking further into an obesity epidemic: BHF High levels of deprivation and easy availability of unhealthy food are driving England's obesity epidemic Sreedevi N R Jun 30, 2026
News Dr Reddy's launches oral semaglutide biosimilar in India Oral semaglutide belongs to the Glucagon-Like Peptide-1 (GLP-1) receptor agonist class of drugs used to improve blood sugar control in adults with type 2 diabetes Shajil Kumar May 21, 2026
Obesity & Weight Management Weight loss rebound risk: 18-month warning for Ozempic and Wegovy users GLP-1 users gain the lost weight within 18 months (four times more) compared with people who go on diet and do exercise Lakshmi Prabha May 05, 2026
News Anti-diabetic drug Metformin may help prevent age-related macular degeneration: Study AMD is an age-related retinal condition causing partial vision loss from the loss of central vision Lakshmi Prabha Mar 24, 2026
News CPPE launches workshop for Type 2 diabetes management New ‘Optimise’ programme focuses on SGLT2 inhibitors, GLP-1 receptor agonists, and person-centred consultation skills Sreedevi N R Mar 11, 2026
Obesity & Weight Management Stopping weight loss jabs can leave some 'worse off than before': Study Cambridge University researchers found that after stopping the jabs for 52 weeks, people on average regained 60 percent of the weight they lost Shajil Kumar Mar 06, 2026
